腹水市场：依腹水类型、腹水严重程度、治疗类型、临床分级、给药途径、通路、最终用户、地区划分

预计到 2025 年，腹水市场价值将达到 14.8 亿美元，到 2032 年将达到 23 亿美元，2025 年至 2032 年的复合年增长率为 6.5%。

全球腹水市场是更广泛的治疗领域中的重要细分市场，该领域旨在解决腹腔内异常积液这种严重疾病。

腹水主要表现为肝硬化的併发症，约占所有病例的80%，但也可能由恶性肿瘤、心臟衰竭、肾臟疾病和其他潜在疾病引起。目前市面上有多种治疗方法，包括利尿剂、腹水穿刺术、经颈静脉肝内门体分流术（TIPS）、腹膜静脉分流术，以及在严重病例中进行肝臟移植。

肝臟疾病，尤其是非酒精性脂肪肝（NAFLD）和酒精性肝病的日益流行，以及全球乙型和丙型肝炎感染病例的不断增加，都显着推高了需要进行腹水治疗的患者数量。此外，全球人口老化以及各种可导致恶性腹水的癌症发生率上升，也进一步扩大了市场规模。

全球医疗系统都认识到腹水对病患和医疗资源带来的沉重负担，因此迫切需要更有效的诊断工具、治疗性介入和管理策略。微创手术的技术进步、新型药物的研发以及诊断影像技术的改进，持续推动市场的发展。

市场动态

全球腹水市场受到几个关键因素的驱动，这些因素支撑着市场的持续增长，主要是由于全球肝硬化患病率的上升，而肝硬化患病率的上升是由于酒精消费量的增加、病毒性肝炎感染以及与肥胖和糖尿病相关的非酒精性脂肪肝疾病的迅速蔓延所致。

已开发国家和开发中国家医疗保健支出的成长扩大了先进诊断程序和治疗方案的覆盖范围，同时，腹腔穿刺术、超音波引导手术以及新型利尿剂配方等技术创新正在改善患者预后和治疗效果。然而，该市场也面临可能阻碍其成长潜力的重大限制因素。

经经皮肝内门静脉分流术（TIPS）和肝移植等先进手术的高昂费用构成了就医障碍，尤其是在医疗基础设施薄弱的新兴经济体。此外，某些手术的侵入性以及对感染疾病和电解质紊乱等併发症的担忧，往往会影响患者的依从性和医生的推荐。

此外，不同医疗体系之间缺乏标准化的治疗通讯协定，以及某些地区对早期诊断和治疗的认识不足，都构成了重大挑战。儘管有这些限制，市场格局仍蕴藏着巨大的机会。人们对个人化医疗的日益关注，以及针对诱发腹水的原发疾病的标靶治疗的研发，为製药公司带来了广阔的前景。亚太和拉丁美洲等新兴市场，由于医疗基础设施的不断改善和医疗意识的提高，蕴藏着巨大的成长潜力。

本次调查的主要特点

• 本报告对全球腹水市场进行了详细分析，以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和復合年增长率（%）。
• 我们将重点介绍各个细分市场的潜在商机，并说明该市场具有吸引力的投资提案矩阵。
• 该研究还提供了有关市场驱动因素、阻碍因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业的竞争策略的重要见解。
• 该研究根据以下参数对全球腹水市场的主要企业进行了分析：公司概况、产品系列、主要亮点、财务表现和策略。
• 本报告的研究结果将使负责人和企业经营团队能够就即将推出的产品、类型升级、市场扩张和行销策略做出明智的决策。
• 这份全球腹水市场报告的目标受众是该行业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
• 相关人员可以透过用于分析全球腹水市场的各种策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

• 调查目的
• 先决条件
• 简称

第二章 市场范围

• 报告概述
  • 市场定义和范围
• 执行摘要

第三章 市场动态、监理及趋势分析

• 市场动态
• 司机
• 抑制因素
• 机会
• 影响分析
• 重大进展
• 法规环境
• 产品上市及核准
• PEST分析
• 波特分析
• 併购趋势
• 产业趋势

4. 2020-2032年全球腹水市场（以腹水类型划分）

• 渗漏性腹水
• 渗出性腹水
• 恶性腹水
• 乳糜腹水
• 出血性腹水
• 感染性腹水

5. 2020-2032年全球腹水市场（以腹水严重程度划分）

• 单纯性腹水
• 復发性/难治性腹水

6. 2020-2032年全球腹水市场依治疗类型划分

• 药物治疗（利尿剂、白蛋白疗法、血管加压素受体拮抗剂、抗生素、标靶癌症治疗）
• 穿刺（治疗性穿刺、大块穿刺、影像引导下穿刺）
• 外科介入手术（经腔肝内门体分流术、腹膜静脉分流术、留置导管及引流系统）
• 其他的

7. 2020-2032年全球腹水市场（依临床等级划分）

• 一年级
• 二年级
• 三年级

8. 2020-2032年全球腹水治疗药物市场（依给药途径划分）

• 口服
• 肠外

9. 2020-2032年全球腹水市场依通路划分

• 医院药房
• 零售药房
• 网路药房

第十章 全球腹水市场（依最终用户划分），2020-2032年

• 医院
• 专科诊所
• 门诊手术中心
• 居家医疗环境

第十一章 2020-2032年全球腹水市场（按地区划分）

• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲国家
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 亚太其他地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东国家
• 非洲
  • 南非
  • 北非
  • 中非

第十二章 竞争格局

• Baxter International
• Fresenius Kabi
• CSL Behring
• Grifols SA
• Pfizer Inc
• Novartis AG
• Otsuka Pharmaceutical
• Bayer AG
• AstraZeneca
• Cook Medical
• Boston Scientific
• Medtronic
• Becton Dickinson
• Cardinal Health
• Teleflex

第十三章 分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十四章 参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Ascites Market is estimated to be valued at USD 1.48 Bn in 2025 and is expected to reach USD 2.30 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.

The global ascites market represents a critical segment within the broader therapeutic landscape, addressing a serious medical condition characterized by abnormal fluid accumulation in the peritoneal cavity.

Ascites primarily manifests as a complication of liver cirrhosis, accounting for approximately 80% of cases, though it can also result from malignancies, heart failure, kidney disease, and other underlying pathological conditions. This market encompasses various treatment modalities including diuretics, paracentesis procedures, transjugular intrahepatic portosystemic shunt (TIPS), peritoneovenous shunts, and liver transplantation in severe cases.

The increasing prevalence of liver diseases, particularly non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease, coupled with rising cases of hepatitis B and C infections globally, has significantly contributed to the growing patient population requiring ascites management. Additionally, the aging global population and increasing incidence of various cancers that can lead to malignant ascites have further expanded the market scope.

Healthcare systems worldwide are recognizing the substantial burden that ascites places on both patients and healthcare resources, driving demand for more effective diagnostic tools, therapeutic interventions, and management strategies. The market continues to evolve with technological advancements in minimally invasive procedures, development of novel pharmaceutical agents, and improved diagnostic imaging techniques.

Market Dynamics

The global ascites market is propelled by several key drivers that collectively contribute to its sustained growth trajectory. The primary driver stems from the escalating prevalence of liver cirrhosis worldwide, fueled by increasing alcohol consumption, viral hepatitis infections, and the rapidly growing epidemic of non-alcoholic fatty liver disease associated with obesity and diabetes.

Rising healthcare expenditure in developed and developing nations has enhanced access to advanced diagnostic procedures and treatment options, while technological innovations in paracentesis techniques, ultrasound-guided procedures, and development of novel diuretic formulations have improved patient outcomes and treatment efficacy. However, the market faces significant restraints that could impede its growth potential.

High treatment costs associated with advanced procedures like TIPS and liver transplantation create accessibility barriers, particularly in emerging economies with limited healthcare infrastructure. The invasive nature of certain procedures and associated complications, including infection risks and electrolyte imbalances, often deter patient compliance and physician recommendations.

Additionally, the lack of standardized treatment protocols across different healthcare systems and insufficient awareness about early diagnosis and management in certain regions pose considerable challenges. Despite these constraints, substantial opportunities exist within the market landscape. The increasing focus on personalized medicine and development of targeted therapies for underlying conditions causing ascites present lucrative prospects for pharmaceutical companies. Emerging markets in Asia-Pacific and Latin America offer significant expansion potential due to improving healthcare infrastructure and rising healthcare awareness.

Key Features of the Study

• This report provides in-depth analysis of the global ascites market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global ascites market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Baxter International, Fresenius Kabi, CSL Behring, Grifols SA, Pfizer Inc, Novartis AG, Otsuka Pharmaceutical, Bayer AG, AstraZeneca, Cook Medical, Boston Scientific, Medtronic, Becton Dickinson, Cardinal Health, and Teleflex
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global ascites market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ascites market

Market Segmentation

• Ascites Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Transudative Ascites
  • Exudative Ascites
  • Malignant Ascites
  • Chylous Ascites
  • Hemorrhagic Ascites
  • Infectious Ascites
• Ascites Severity Insights (Revenue, USD Bn, 2020 - 2032)
  • Uncomplicated Ascites
  • Recurrent/Refractory Ascites
• Treatment Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Medication (Diuretics, Albumin Therapy, Vasopressin Receptor Antagonists, Antibiotics, Targeted Cancer Therapy)
  • Paracentesis (Therapeutic Paracentesis, Large-Volume Paracentesis, Image-Guided Paracentesis)
  • Surgical Interventional Procedures (TIPS, Peritoneovenous Shunt, Indwelling Catheters & Drainage Systems)
  • Others
• Clinical Grade Insights (Revenue, USD Bn, 2020 - 2032)
  • Grade 1
  • Grade 2
  • Grade 3
• Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
  • Oral
  • Parenteral
• Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Baxter International
  • Fresenius Kabi
  • CSL Behring
  • Grifols SA
  • Pfizer Inc
  • Novartis AG
  • Otsuka Pharmaceutical
  • Bayer AG
  • AstraZeneca
  • Cook Medical
  • Boston Scientific
  • Medtronic
  • Becton Dickinson
  • Cardinal Health
  • Teleflex

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Ascites Market, By Ascites Type
  • Global Ascites Market, By Ascites Severity
  • Global Ascites Market, By Treatment Type
  • Global Ascites Market, By Clinical Grade
  • Global Ascites Market, By Route of Administration
  • Global Ascites Market, By Distribution Channel
  • Global Ascites Market, By End User
  • Global Ascites Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Ascites Market, By Ascites Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Transudative Ascites
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Exudative Ascites
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Malignant Ascites
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chylous Ascites
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hemorrhagic Ascites
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Infectious Ascites
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Ascites Market, By Ascites Severity, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Uncomplicated Ascites
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Recurrent/Refractory Ascites
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Ascites Market, By Treatment Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Medication (Diuretics, Albumin Therapy, Vasopressin Receptor Antagonists, Antibiotics, Targeted Cancer Therapy)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Paracentesis (Therapeutic Paracentesis, Large-Volume Paracentesis, Image-Guided Paracentesis)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Surgical Interventional Procedures (TIPS, Peritoneovenous Shunt, Indwelling Catheters & Drainage Systems)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Ascites Market, By Clinical Grade, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Grade 1
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Grade 2
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Grade 3
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Ascites Market, By Route of Administration, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Parenteral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Ascites Market, By Distribution Channel, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Ascites Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Home Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Ascites Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Ascites Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Ascites Severity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Grade, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Ascites Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Ascites Severity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Grade, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Ascites Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Ascites Severity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Grade, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Ascites Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Ascites Severity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Grade, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Ascites Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Ascites Severity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Grade, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Ascites Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Ascites Severity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Grade, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

12. Competitive Landscape

• Baxter International
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fresenius Kabi
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CSL Behring
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Grifols SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Otsuka Pharmaceutical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AstraZeneca
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cook Medical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boston Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Becton Dickinson
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cardinal Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teleflex
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

13. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

14. References and Research Methodology

• References
• Research Methodology
• About us